Senior Leadership
TK Rao, Ph.D.
Founder and Chairman of the Board
Dr. Rao, founder and Chairman of the Board of the Directors at Integrated Laboratory Systems, Inc. (ILS). He graduated with a Ph.D. from Florida State University. Before starting ILS, he worked as a Staff Biologist at Oak Ridge National Laboratory in Tennessee and Senior Research Scientist at Northrop Services, Inc. in North Carolina. Dr. Rao served on various professional organizations such as The Environmental Mutagen Society, Genetic Toxicology and Environmental Mutagen Society, Southeastern Cancer Research Association and The National Contract Management Association. He has edited one reference book and has published over 150 technical publications and presentations.
Tom Goldsworthy, Ph.D.
President and Chief Executive Officer
Dr. Goldsworthy is not only the President and CEO for Integrated Laboratory Systems, Inc (ILS) but is also a member of the Board of Trustees. Prior to his current position, he served as the Chief Operating Officer, Senior Vice President, and the Director of the Health Sciences Division at ILS. As President and CEO, Dr. Goldsworthy works closely with the Chairman of the Board to provide the executive leadership for making ILS a successful company and a cherished place to work by all employees. Dr. Goldsworthy has over 25 years of experience as an experimental pathologist and toxicologist, specializing in cancer research, mechanisms of disease, and human risk assessment. Before joining ILS, Dr. Goldsworthy served as a Staff Scientist at the Chemical Industry Institute of Toxicology (Research Triangle Park, NC), where he directed the carcinogenesis research program investigating the role of growth alterations, cell cycle regulation, gene expression, and gene mutation in the induction of cancer. He is widely recognized by his peers for his scientific vision and integrity, management experience, and motivational skills. Dr. Goldsworthy received his Ph.D. in Pathology and Oncology from the McArdle Laboratory for Cancer Research, University of Wisconsin-Madison.
Publications
Sam Tetlow, MBA
Chief Business Officer
Phone: 919 281-1110
Email: (JavaScript must be enabled to view this email address)
Mr. Tetlow is the Chief Business Officer for ILS. He has 20 years of experience with a focus in life science investing, business development and mergers & acquisitions. Mr. Tetlow is responsible for working with the Chairman of the Board and the executive leadership team to set the Company’s overall strategy, and grow the business both organically and strategically. He works closely with the CEO to reinforce the company’s values across the company and expand ILS capabilities in important areas of research and medicine. Previously, Mr. Tetlow was with Calvert Research, where he was instrumental in setting the strategic direction of the firm’s drug compounds and technologies. Prior to that, Mr. Tetlow was a full time Partner with Research Triangle Ventures, where he led the full cycle of investing, including selected company management roles, for all life science investments. Mr. Tetlow has a Bachelor’s of Science in Aerospace Engineering from Worcester Polytechnic Institute (honors) and a MBA from UNC Kenan-Flagler Business School (honors).
Barbara Vinesett, CPA
Chief Financial Officer
Ms. Vinesett has over 20 years of accounting/finance experience. She was promoted to Chief Financial Officer (CFO) in 2003 and appointed to the Board of Trustees in 2005. She works with the Board of Trustees to establish long-range goals and strategies. She is responsible for all aspects of ILS' financial and accounting operations, and resource allocation. Ms. Vinesett is a Certified Public Account and holds a B.S. in Accounting from Greensboro College.
Michael Waters, Ph.D.
Chief Scientific Officer
Dr. Waters is the Chief Scientific Officer (CSO) at ILS. He left the position of Assistant Director for Database Development, National Center for Toxicogenomics, National Institute of Environmental Health Sciences (NIEHS), RTP, NC, where for six years he was responsible for a major initiative to develop the Chemical Effects in Biological Systems (CEBS) knowledgebase. While at the NIEHS, Dr. Waters served on the Bioinformatics and Computational Biology Roadmap Working Group and the Food and Drug Administration Advisory Committee for Pharmaceutical Science, Pharmacology, and Toxicology Subcommittee. He also served on the Toxicogenomics and Risk Assessment Committee of the International Programme on Chemical Safety, and the Advisory Boards of the Microarray Gene Expression Data Society.
A widely published scientist, Dr. Waters is Editor of Mutation Research-Reviews in Mutation Research and the Toxicology Series of the Royal Society of Chemistry (UK). He holds the rank of Adjunct Professor at the University of North Carolina at Chapel Hill (since 1979), and at Duke University in Durham, NC (since 1992). He has served as President of the Environmental Mutagen Society, and the International Association of Environmental Mutagen Societies. He is an international scientific leader, and his databases and several of his papers are recognized as important advances that have significantly impacted the fields of genetic toxicology, carcinogenesis, toxicogenomics, and risk assessment. His scientific credentials include a B.S. in Pre-Medicine from Davidson College, Davidson, NC in 1964 and Ph.D. in Biochemistry from the University of North Carolina at Chapel Hill in 1969. His military tour was with the U.S. Army Reserve, (1969-1971) rank of captain.
Publications
Brad Blackard, MSPH
Chief Operations Officer
Mr. Blackard has over 20 years of experience in the environmental health science industry and over 15 years experience managing federal contracts. After serving as a Program Manager for six years and Director of Operations for two years, he is now the Chief Operations Officer (COO) for ILS. His role as COO includes managing the daily and long-term operational aspects of the company including Information Technology, Quality Assurance, Health and Safety, Project Management, and Facility Administration. He works with the CEO to assure the aggressive and successful growth of the company. Mr. Blackard holds a B.S. in Zoology from North Carolina State University, and an MSPH in Environmental Sciences and Engineering, Environmental Management and Policy from the University of North Carolina.
Kevin Causey, MBA
Director of Business Development - Commercial
Phone: 919 281-1110
Email: (JavaScript must be enabled to view this email address)
Mr. Causey has 10 years of experience in the pharmaceutical, health science, and chemical industries. After several years serving in a dual role overseeing Project Management and Commercial Business his focus has shifted to direct ILS’s commercial business strategies. As Director of Commercial Development Mr. Causey’s primary responsibilities are sales, marketing, customer engagement, and partnerships. He is a member of the Senior Leadership Team with the CEO and Board of Directors to strategically position ILS for continued industry leadership in the future. Mr. Causey received a B.S. in Biological Sciences from North Carolina State University in 2001, and an MBA from Pfeiffer University in 2006.
Marc Jackson
Director of Business Development - Government
Phone: 919 281-1110
Email: (JavaScript must be enabled to view this email address)
Mr. Jackson has over 30 years experience in government contracting. His responsibilities include: identifying procurement opportunities in government agencies; monitoring external markets and growth in internal capabilities to develop new market segments; interacting with procurement officials and policy makers to direct ILS growth targets; representing scientific programs in identifying growth opportunities; and providing leadership to the ILS bid and proposal process. Prior to his role in business development, Mr. Jackson supported research in genetic and general toxicology. His contribution to reports and publications for the U.S. Environmental Protection Agency, the National Institute of Environmental Health Sciences, National Toxicology Program, and the International Agency for Research on Cancer have been used to assess potential for exposure and subsequent adverse effects in humans. Mr. Jackson holds a B.A. in Biology from Asbury University.
Mary Mulleady, PMP
Director of Business Management
Mrs. Mulleady has over 19 years of experience in Contract Administration, including oversight and management of both Federal and Commercial contracts. This experience also includes development and management of purchasing and travel policies and procedures. She is currently responsible for managing the Contracts, Proposal Development, Purchasing, and Travel departments for the company. Mrs. Mulleady holds a B.A. from Virginia Polytechnic Institute and State University.
Jason Shannon, PHR
Director of Human Resources
Mr. Shannon has over 11 years of human resources experience. He works closely with executives, directors, managers, and staff, serving as the principal contact for all human resource issues. He is responsible for developing best practice policies and procedures in the areas of compensation, benefits, recruitment, performance management, and labor relations. Mr. Shannon holds a B.S. in Human Resources Management from Barton College and is certified as a Professional in Human Resources from the Human Resources Certification Institute.